Abstrakt

Przypisy

• 1. Bansal V.S., Vaidya S., Somers E.P., Kanuga M., Shevell D., WeikelR., Detmers P.A.: Small molecule antagonists of complement receptortype 3 block adhesion and adhesion-dependent oxidative burstin human polymorphonuclear leukocytes. J. Pharmacol. Exp. Ther.,2003; 304: 1016-1024
  Google Scholar
• 2. Cheng A.C., Stephens D.P., Currie B.J.: Granulocyte colony stimulatingfactor (G-CSF) as an adjunct to antibiotics in the treatmentof pneumonia ain adults. Cochrane Database Syst. Rev., 2003;4: CD004400
  Google Scholar
• 3. Crawford J.: Pegfilgrastim administered once per cycle reducesincidence of chemotherapy-induced neutropenia. Drugs, 2002; 62(Suppl. 1): 89-98
  Google Scholar
• 4. Davis K.A., Fabian T.C., Ragsdale D.N., Trenthem L.L., Croce M.A.,Proctor K.G.: Granulocyte colony-stimulating factor and neutrophil–related changes in local host defense during recovery from shockand intra-abdominal sepsis. Surgery, 1999; 126: 305-313
  Google Scholar
• 5. Gianotti L., Solomkin J.S., Munda R., Alexander J.W.: Failure of localand systemic bacterial clearance in rats with acute pancreatitis.Pancreas, 1995; 10: 78-84
  Google Scholar
• 6. Hartung T.: Anti-inflammatory effects of granulocyte colony-stimulatingfactor. Curr. Opin. Hematol., 1998; 5: 221-225
  Google Scholar
• 7. Hatano N., Sugiyama M., Watanabe T., Atomi Y.: Opsonin receptorexpression on peritoneal exudative and circulatory neutrophils inmurine acute pancreatitis. Pancreas, 2001; 23: 55-61
  Google Scholar
• 8. Höglund M., Hakansson L., Venge P.: Effects of in vivo administrationof G-CSF on neutrophil functions in healthy volunteers. Eur. J.Haematol., 1997; 58: 195-202
  Google Scholar
• 9. Minatoguchi S., Takemura G., Chen X.H., Wang N., Uno Y., KodaM., Arai M., Misao Y., Lu C., Suzuki K., Goto K., Komada A., TakahashiT., Kosai K., Fujiwara T., Fujiwara H.: Acceleration of the healingprocess and myocardial regeneration may be important as a mechanismof improvement of cardiac function and remodeling bypostinfarction granulocyte colony-stimulating factor treatment.Circulation, 2004; 109: 2572-2580
  Google Scholar
• 10. Ninomiya H., Muraki Y., Shibuya K., Nagasawa T., Abe T.: Inductionof Fcg R-III (CD16) expression on neutrophils affected by paroxysmalnocturnal haemoglobinuria by administration of granulocytecolony-stimulating factor. Br. J. Haematol., 1993; 84: 497-503
  Google Scholar
• 11. Petrov M.S., Chong V., Windsor J.A.: Infected pancreatic necrosis:not necessarily a late event in acute pancreatitis. World J. Gastroenterol.,2011; 17: 3173-3176
  Google Scholar
• 12. Rao R., Prinz R.A., Kazantsev G.B., Hecht D., Gattuso P., JacobsH.K., Djuricin G., Castelli M.: Effects of granulocyte colony-stimulatingfactor in severe pancreatitis. Surgery, 1996; 119: 657-663
  Google Scholar
• 13. Roilides E., Walsh T.J., Pizzo P.A., Rubin M.: Granulocyte colony-stimulatingfactor enhances the phagocytic and bactericidalactivity of normal and defective human neutrophils. J. Infect. Dis.,1991; 163: 579-583
  Google Scholar
• 14. Schneider C., von Aulock S., Zedler S., Schinkel C., Hartung T.,Faist E.: Perioperative recombinant human granulocyte colony-stimulatingfactor (Filgrastim) treatment prevents immunoinflammatorydysfunction associated with major surgery. Ann. Surg., 2004;239: 75-81
  Google Scholar
• 15. Sugiyama M., Hatano N., Watanabe T., Atomi Y.: Acute necrotizingpancreatitis reduces opsonin receptor expression on peritonealexudative neutrophils in mice. Hepatogastroenterology, 2005;52: 1591-1595
  Google Scholar
• 16. Tang T., Rosenkranz A., Assmann K.J., Goodman M.J., Gutierrez–Ramos J.C., Carroll M.C., Cotran R.S., Mayadas T.N.: A role for Mac-1(CDIIb/CD18) in immune complex-stimulated neutrophil function invivo: Mac-1 deficiency abrogates sustained Fcg receptor-dependentneutrophil adhesion and complement-dependent proteinuria in acuteglomerulonephritis. J. Exp. Med., 1997; 186: 1853-1863
  Google Scholar

Pełna treść artykułu